Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 10, 2022 07:30 ET | Source: OpGen, Inc.

OpGen Announces Preliminary Unaudited Revenue for Fiscal 2021 and Provides Business Update

Preliminary unaudited revenue for 2021 was approximately $4.3 millionMaintained strong balance sheet with $36.1 million cash as of December 31, 2021 and total capital raised in 2021 of $51.2...
December 14, 2021 07:30 ET | Source: OpGen, Inc.

OpGen subsidiary Ares Genetics announces the strategic expansion of ARESdb proprietary contents

Following successful completion of Phase 1, Ares Genetics has now entered into Phase 2 of its collaboration with a leading U.S. CRO and reference lab, gaining access to 1,000 proprietary clinical...
December 08, 2021 16:30 ET | Source: OpGen, Inc.

OpGen Announces Results of Special Meeting of Stockholders

ROCKVILLE, Md., Dec. 08, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), a precision medicine company harnessing the power of molecular diagnostics and informatics to...
November 30, 2021 08:45 ET | Source: OpGen, Inc.

OpGen Subsidiary Ares Genetics Announces Strategic Database Access Transaction

Ares Genetic is granting a permanent, unrestricted and non-exclusive access to a small subset of the proprietary ARESdb data asset to an unnamed global corporation and leader in microbiology and...
November 11, 2021 16:05 ET | Source: OpGen, Inc.

OpGen Reports Third Quarter 2021 Financial Results and Provides Business Update

Total Revenue for Q3 2021 was approximately $1.2 millionCash as of September 30, 2021, was approximately $25.4 million, up significantly from the $13.4 million at year-end 2020Cash balance was further...
November 04, 2021 07:30 ET | Source: OpGen, Inc.

OpGen Announces Special Meeting of Stockholders to Vote on Proposed Increase to Number of Authorized Shares of Common Stock

ROCKVILLE, Md., Nov. 04, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), a precision medicine company harnessing the power of molecular diagnostics and informatics to...
November 04, 2021 07:30 ET | Source: OpGen, Inc.

OpGen Appoints Albert Weber as Chief Financial Officer

Albert Weber to join OpGen as OpGen’s CFO effective January 1, 2022 from U.S.-German molecular diagnostics company EpigenomicsAnnounces inducement grant of 210,000 stock options under NASDAQ Listing...
October 28, 2021 07:30 ET | Source: OpGen, Inc.

OpGen to Provide Business Update and Financial Results for the Third Quarter 2021 on November 11th at 4:30 p.m. Eastern Time

ROCKVILLE, Md., Oct. 28, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its third quarter...
October 21, 2021 07:30 ET | Source: OpGen, Inc.

OpGen Subsidiary Ares Genetics Launches AREScloud

AREScloud is a new, commercial web application aimed at accelerating the analysis of sequenced clinical isolatesAREScloud offers an advanced solution for infection prevention and control ROCKVILLE,...
October 18, 2021 16:30 ET | Source: OpGen, Inc.

OpGen Announces Closing of $15 Million Registered Direct Offering

ROCKVILLE, Md., Oct. 18, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics...